Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 45 of 6351
-
Could a cheap blood thinner cut stroke risk in africa?
Prevention Not yet recruitingGlobal estimates suggest that sub-Saharan Africa (SSA) now has the highest incidence, prevalence, and worst survival outcomes of stroke. With an estimated 1.4 million stroke survivors, outcomes of stroke in SSA are abysmal with 1-month case fatality at 30% and 3-year mortality ra…
Phase 3 • Sponsor: Northern California Institute of Research and Education • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Precision radiation may boost hormone therapy for advanced prostate cancer
Disease control Not yet recruitingThis is a multicenter, randomized, open-label phase 2 study for men with metastatic hormone-sensitive prostate cancer. About 254 participants will first receive 6 months of darolutamide plus androgen deprivation therapy. Participants whose cancer has not progressed and who still …
Phase 2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Clot-Removal procedure may offer hope for severe brain stem strokes
Disease control Not yet recruitingAcute basilar artery occlusion is associated with high mortality and severe disability. Previous randomized trials have demonstrated the benefit of endovascular therapy in selected patients with basilar artery occlusion; however, patients with large ischemic core, commonly define…
Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Heart pump may help High-Risk patients get Life-Saving artery treatment
Disease control Not yet recruitingBased on a multi-center randomized controlled study, this research aims to evaluate the efficacy and safety of interventional therapy supported by the CorVad percutaneous left ventricular assist system (Micro-axial Flow Pump) for patients with complex coronary heart disease (CHD)…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can a burst of radiation make CAR t-cells fight cancer harder?
Disease control Not yet recruitingThis is a clinical trial to evaluate the safety of combining CAR T-cell therapy with low-dose total body irradiation (LD-TBI) in patients with previously treated large B-cell lymphoma (LBCL) or multiple myeloma (MM). The investigators' hypothesis is that the combination will make…
Phase 1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a Low-Dose clot buster boost recovery after stroke clot removal?
Disease control Recruiting nowThe NEWLINE trial is a multicenter, randomized, open-label, blinded endpoint (PROBE) trial evaluating whether adjunctive low-dose intra-arterial alteplase administered immediately after successful endovascular thrombectomy improves functional outcomes in adults with acute ischemi…
Phase 3 • Sponsor: 115 People's Hospital • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a precision drug outsmart hard-to-treat colorectal cancer?
Disease control Not yet recruitingThis trial is a registrational Phase III, randomized, open-label, multicenter study designed to evaluate the efficacy and safety of BL-M07D1 in patients with advanced colorectal cancer who have HER2 IHC3+ and have failed prior treatment with oxaliplatin, fluorouracil and irinotec…
Phase 3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a clip fix a leaky heart valve without open surgery?
Disease control Not yet recruitingAtrial functional mitral regurgitation (AFMR) develops when enlargement and remodeling of the left atrium and mitral annulus prevent the mitral valve leaflets from closing completely, allowing blood to leak backward through the valve. For patients with significant AFMR who remain…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Laser zap before eye injection could cut needle count for wet AMD
Disease control Not yet recruitingBackground: Age-related macular degeneration (AMD) is a common eye disease that can cause blindness in older adults. The "wet" form of AMD, called neovascular AMD, happens when abnormal blood vessels grow under the retina and leak fluid. The current standard treatment requires re…
Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can brain implants read and treat bipolar depression without triggering mania?
Disease control Recruiting nowThis study addresses a critical unmet need in the treatment of bipolar disorder by investigating whether Subcallosal Cingulate (SCC) Deep Brain Stimulation (DBS) can safely and effectively treat treatment-resistant bipolar depression without inducing manic switches. The researche…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a pill tackle Tough-to-Treat leukemia?
Disease control Recruiting nowThe goal of this study is to evaluate the safety of CHM-029, an investigational oral medicine, and to evaluate its activity in treating certain types of acute myeloid leukemia (AML) in adults. The main questions the study aims to answer are: * What is an appropriate dose of CHM-…
Phase 1 • Sponsor: Charm Therapeutics • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a new drug boost the fight against esophageal cancer?
Disease control Not yet recruitingAn open-label, multicenter, randomized, phase II clinical trial to evaluate the safety, tolerability and efficacy of SHR-9839(sc) as monotherapy or in combination with chemotherapy plus adebelimab in patients with advanced esophageal squamous cell carcinoma (ESCC).
Phase 2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a new pill outsmart Treatment-Resistant blood cancer?
Disease control Not yet recruitingTo Evaluate the Efficacy and Safety of TQB3909 Tablets versus Investigator's Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Phase 3 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
AI ultrasound could unmask silent heart disease in seniors
Diagnosis Not yet recruitingHeart valve disease and weakened heart muscle (left ventricular systolic dysfunction) are common in older adults and often go undetected until serious complications such as heart failure develop. Detection currently depends on a clinician hearing a murmur and then ordering an ech…
Sponsor: University of Texas Southwestern Medical Center • Aim: Diagnosis
Last updated Aug 19, 2026 00:00 UTC
-
Could a painless microneedle pad ease Raynaud's in scleroderma?
Disease control Not yet recruitingRaynaud's Phenomenon (RP), a vasospastic disorder causing digital ischemia and potential tissue necrosis, is effectively treated with Botulinum Toxin Type A (BTX-A) in refractory cases. However, standard administration requires painful, invasive injections that risk infection and…
Phase 3 • Sponsor: Khon Kaen University • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a new drug combo make stem cell transplants safer for frail AML patients?
Cure Not yet recruitingThis study evaluates the effectiveness and safety of a new conditioning regimen called VABu before stem cell transplantation in patients with acute myeloid leukemia (AML) who are in their first complete remission (CR1), classified as non-high-risk per ELN 2022 guidelines, but hav…
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Cure
Last updated Aug 21, 2026 00:00 UTC
-
Can a CBD-Based drug stop seizures before they start?
Prevention Not yet recruitingPatients with Sturge-Weber syndrome (SWS) are frequently affected by seizures, and seizures are associated with poorer neurological outcomes. To date there is no established means of predicting or preventing seizure onset. Cannabidiol (Epidiolex) was well tolerated in an open lab…
Phase 2 • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Aug 28, 2026 00:00 UTC
-
Brain implants and nerve stimulation put to the test for untreatable depression
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate whether precision closed-loop neuromodulation treatments can improve depressive symptoms and daily functioning in people with treatment-resistant major depressive disorder (TRD). The study will assess the effectiveness and safety of …
Sponsor: Shanghai Mental Health Center • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Brain implant may turn thoughts into speech for people with aphasia
Disease control Not yet recruitingThe purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with aphasia to generate text on a computer screen and audible, computer-generated speech by attempting to speak.
Sponsor: Leigh R. Hochberg, MD, PhD. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a new drug combo boost remission in adult leukemia?
Disease control Not yet recruitingThis study is designed as a prospective, single-arm, exploratory clinical trial based on lishatoclax, enrolling three independent cohorts of patients with Philadelphia chromosome-positive (Ph⁺) ALL, Philadelphia chromosome-negative (Ph-) ALL, and T-cell ALL (T-ALL). By investigat…
Sponsor: LanZhou University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC